WELL Health - Public Comps and Valuation Multiples

WELL Health Overview

About WELL Health

WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth. WELL Health USA Patient Services includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing and SaaS and Technology Services. It generates the majority of its revenue from Well Health USA Patient and Provider Services unit.

Founded

2010

HQ

Employees

3.2K+

Website

well.company

Sectors

Hospitals & Clinics

Financials

LTM Revenue $940M

LTM EBITDA $119M

EV

$1.2B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

WELL Health Financials

As of September 2025, WELL Health reported last 12-month revenue of $940M and EBITDA of $119M.

In the same period, WELL Health generated $403M in LTM gross profit and $7.2M in net income.

See WELL Health valuation multiples based on analyst estimates

WELL Health P&L

In the most recent fiscal year, WELL Health reported revenue of $655M and EBITDA of $83.2M.

WELL Health expects next 12-month revenue of XXX and NTM EBITDA of XXX

See WELL Health valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$940M	XXX	$655M	XXX	XXX	XXX
Gross Profit	$403M	XXX	$259M	XXX	XXX	XXX
Gross Margin	43%	XXX	39%	XXX	XXX	XXX
EBITDA	$119M	XXX	$83.2M	XXX	XXX	XXX
EBITDA Margin	13%	XXX	13%	XXX	XXX	XXX
EBIT	$53.1M	XXX	-$21.9M	XXX	XXX	XXX
EBIT Margin	6%	XXX	-3%	XXX	XXX	XXX
Net Profit	$7.2M	XXX	$23.2M	XXX	XXX	XXX
Net Margin	1%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	$152M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for WELL Health including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $940M. EBITDA for the last twelve months was $119M. In the most recent fiscal year, WELL Health achieved $655M in revenue and $83.2M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$940M	Analyst estimates available to subscribers	$655M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$403M	Analyst estimates available to subscribers	$259M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	42.9% gross margin	Analyst estimates available to subscribers	39.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$119M	Analyst estimates available to subscribers	$83.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	12.7% EBITDA margin	Analyst estimates available to subscribers	12.7% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$53.1M	Analyst estimates available to subscribers	-$21.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	5.6% EBIT margin	Analyst estimates available to subscribers	-3.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$7.2M	Analyst estimates available to subscribers	$23.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	0.8% net profit margin	Analyst estimates available to subscribers	3.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$152M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for WELL Health

This financial data table provides comprehensive performance metrics for WELL Health, a company based in Canada. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

WELL Health generated $940M in revenue over the last twelve months.
The company achieved $119M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $403M.
Net income over the last twelve months reached $7.2M.

Fiscal Year Performance

In the most recent fiscal year, WELL Health reported $655M in total revenue.
Fiscal year EBITDA was $83.2M.
The company maintained a gross profit margin of 39.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 12.7%.
Net profit margin reached 3.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for WELL Health. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

WELL Health Stock Performance

WELL Health has current market cap of CAD 1.2B (or $882M), and EV of CAD 1.7B (or $1.2B).

Market Cap Evolution

WELL Health Stock Data

As of October 17, 2025, WELL Health's stock price is CAD 5 (or $3).

See WELL Health trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.2B	$882M	XXX	XXX	XXX	XXX	$0.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

WELL Health Valuation Multiples

WELL Health's trades at 1.9x EV/Revenue multiple, and 14.6x EV/EBITDA.

See valuation multiples for WELL Health and 15K+ public comps

WELL Health Financial Valuation Multiples

As of October 17, 2025, WELL Health has market cap of $882M and EV of $1.2B.

Equity research analysts estimate WELL Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

WELL Health has a P/E ratio of 123.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$882M	XXX	$882M	XXX	XXX	XXX
EV (current)	$1.2B	XXX	$1.2B	XXX	XXX	XXX
EV/Revenue	1.3x	XXX	1.9x	XXX	XXX	XXX
EV/EBITDA	10.2x	XXX	14.6x	XXX	XXX	XXX
EV/EBIT	22.9x	XXX	-55.5x	XXX	XXX	XXX
EV/Gross Profit	3.0x	XXX	n/a	XXX	XXX	XXX
P/E	123.2x	XXX	38.0x	XXX	XXX	XXX
EV/FCF	21.8x	XXX	-254.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get WELL Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

WELL Health Margins & Growth Rates

WELL Health's last 12 month revenue growth is 16%

WELL Health's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

WELL Health's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

WELL Health's rule of X is 53% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for WELL Health and other 15K+ public comps

WELL Health Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	16%	XXX	30%	XXX	XXX	XXX
EBITDA Margin	13%	XXX	13%	XXX	XXX	XXX
EBITDA Growth	22%	XXX	33%	XXX	XXX	XXX
Rule of 40	31%	XXX	29%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	53%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	9%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	43%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial